NASDAQ : DRTS
$0 (0.0%)
%
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
-
-
change: 0.0 | last:
-
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-07-24 | Uzi Sofer | 13.7M | 15.80% |
| 2025-05-01 | Oramed Pharmaceuticals Inc. | 14.11M | 19.99% |
| 2025-05-01 | Oramed Ltd. | 14.11M | 19.99% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $4.95 | 80.58M | $398.88M | $15.98M | $13.73M | $396.63M |
| 2024-12-31 | $3.10 | 69.93M | $216.78M | $13.72M | $12.54M | $215.59M |
| 2023-12-31 | $3.00 | 69.38M | $208.13M | $12.66M | $13.28M | $208.75M |
| 2022-12-31 | $3.18 | 63.53M | $202.04M | $5.84M | $5.19M | $201.4M |
| 2021-12-31 | $9.82 | 40.53M | $397.99M | $23.24M | $53.96M | $428.72M |
| 2020-12-31 | $10.10 | 40.43M | $408.38M | $15.6M | $53.96M | $446.75M |
| 2019-12-31 | $10.10 | 67.62M | $682.98M | $1.83M | -$ | $681.15M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7.07 | 89.71M | $634.22M | $8.44M | $14.34M | $640.11M |
| 2025-12-31 | $4.95 | 85.67M | $424.05M | $12.2M | $13.73M | $425.58M |
| 2025-09-30 | $4.51 | 83.75M | $377.72M | $3.33M | $13.5M | $387.89M |
| 2025-06-30 | $3.12 | 80.35M | $250.7M | $11.7M | $13.31M | $252.31M |
| 2025-03-31 | $2.51 | 70.45M | $176.83M | $5.02M | $12.29M | $184.11M |
| 2024-12-31 | $3.10 | 70.09M | $217.29M | $13.72M | $12.54M | $216.1M |
| 2024-09-30 | $2.38 | 69.9M | $166.36M | $5.53M | $12.56M | $173.4M |
| 2024-06-30 | $2.55 | 69.87M | $178.17M | $2.76M | $12.56M | $187.97M |
| 2024-03-31 | $2.90 | 69.71M | $202.17M | $10.42M | $12.94M | $204.69M |
| 2023-12-31 | $3.00 | 69.67M | $209.01M | $15.81M | $13.28M | $206.48M |
| 2023-09-30 | $3.79 | 69.47M | $263.31M | $82000 | $6.05M | $269.28M |
| 2023-06-30 | $4.37 | 69.32M | $302.91M | $855K | $6.28M | $308.33M |